Published Studies Related to Ergotamine and Caffeine (Ergotamine / Caffeine)
Well-designed clinical trials related to Ergotamine and Caffeine (Ergotamine / Caffeine)
The analgesic and antiemetic efficacy of gabapentin or ergotamine/caffeine for the treatment of postdural puncture headache. [2011.06.01]
Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy. [2007.03]
[Comparison of the effectiveness of lysine acetylsalicylate and metoclopramide combination with ergotamine plus caffeine in the treatment of migraine attacks] [2004]
[The effectiveness of ergotamine treatment in chronic headache disorders: a double-blind, randomized, crossover, placebo controlled trial] [2003]
Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine. [2003]
Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. [2002]
Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks. [1999.01]
Peripheral vascular effects and pharmacokinetics of the antimigraine compound, zolmitriptan, in combination with oral ergotamine in healthy volunteers. [1997.10]
Well-designed clinical trials possibly related to Ergotamine and Caffeine (Ergotamine / Caffeine)
Sumatriptan (subcutaneous route of administration) for acute migraine attacks in
adults. [2012]
Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study. [2004.02]
Oral sumatriptan for acute migraine. [2003]
Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine. [2002.10]
Sumatriptan: a selective 5-hydroxytryptamine receptor agonist for the acute treatment of migraine. [1992.06]
Other research related to Ergotamine and Caffeine (Ergotamine / Caffeine)
[Angiospastic occlusion of the superficial femoral artery by chronic ergotamine intake]. [2011.01]
The analgesic and antiemetic efficacy of gabapentin or ergotamine/caffeine for
the treatment of postdural puncture headache. [2011]
[Almotriptan vs. ergotamine plus caffeine for acute migraine treatment. A cost-efficacy analysis] [2009.04]
Ergotamine use in severe diabetic autonomic neuropathy. [2006.05]
Possible ergotamine-caffeine-associated delirium. [2002.01]
Patterns of ergotamine and sumatriptan use in the Netherlands from 1991 to 1997. [2001.06]
Pheochromocytoma crisis caused by contemporary ergotamine, caffeine, and nimesulide administration. [1997.12]
Economic evaluation of oral sumatriptan compared with oral caffeine/ergotamine for migraine. [1997.11]
Dosing and administration of ergotamine tartrate and dihydroergotamine. [1997]
Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature. [1996.03]
[The comparison of sodium valproate and ergotamine titrate plus caffeine in the abortive treatment of migraine attacks] [1995.11]
[Daily chronic headache in patients with migraine induced by abuse of ergotamine-analgesics: response due to a protocol of outpatient treatment] [1993.08]
Vascular injuries in ergotamine abuse: a case report. [1993.07]
Placebo-controlled clinical trials with ergotamine in the acute treatment of migraine. [1993.06]
Ergotamine: its use in the treatment of migraine and its complications. [1992.04]
Abortive migraine therapy with oral naproxen sodium plus metoclopramide plus ergotamine tartrate with caffeine. [1992.02]
[Headache caused by analgesic and/or ergotamine abuse] [1991.05.15]
Spasm of arm arteries due to ergotamine tartrate. A case report. [1991.01]
Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine. [1988.06]
Other possibly related research studies
Chronic ergot toxicity presenting with bilateral external iliac artery dissection and lower extremity rest pain. [2006.11]
Spotlight on eletriptan in migraine. [2006]
Medication-overuse headache in patients with cluster headache. [2006.07.11]
Eletriptan: a review of its use in the acute treatment of migraine. [2006]
Acute migraine treatment: patterns of use and satisfaction in a clinical population. [2006.05]
Safety and efficacy of eletriptan in the treatment of acute migraine. [2006.01]
Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine. [2005]
Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. [2006.02]
Fixed drug combinations for the acute treatment of migraine : place in therapy. [2005]
Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine. [2005]
Eletriptan review. [2005.04]
Eletriptan in migraine. [2005.01]
Transcranial Doppler ultrasonographic features during drug withdrawal from drug-induced headache. A transcranial Doppler follow-up study. [1998.10]
Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. [2004.06]
Overuse of symptomatic medications among chronic (transformed) migraine patients: profile of drug consumption. [2003.03]
Gateways to Clinical Trials. [2002.09]
Syndrome of cerebrospinal fluid hypovolemia following lumbar puncture cerebrospinal fluid leak in a patient with idiopathic intracranial hypertension. [2002.01]
[Critical ischaemia of the limbs and localized livedo in a case of ergotism] [2002.01.25]
An unusual case of clarithromycin associated ergotism. [2001.11]
When should triptans be taken during a migraine attack? [2001]
[Analgesic-induced chronic headache] [2001.04]
Successful withdrawal from analgesic abuse in a group of youngsters with chronic daily headache. [2001.06]
Pharmacology and efficacy of eletriptan for the treatment of migraine attacks. [2000.12]
[Emergency treatment of migraine attacks with particular reference to agonists of 5-HT1B/1D receptor] [1999]
Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. [2000.09]
Chronic ergot toxicity: A rare cause of lower extremity ischemia. [2000.06]
[Intractable vomiting, convulsions and megaloblastic anemia: anamnesis, key to diagnosis] [1999.07.03]
Diclofenac-potassium in migraine: a review. [1999.06]
Limb-threatening lower extremity ischemia successfully treated with intra-arterial infusion--case reports. [1999.03]
Ergotism and vascular insufficiency: a case report and review of literature. [1998.03]
[Clinical features of daily chronic headache] [1997.07]
Correlation of prenatal events with the development of polymicrogyria. [1995.04]
Pharmacological rationale for the clinical use of caffeine. [1995.01]
[Acute ischemia of an arm as an unusual manifestation of ergotism] [1994.11.04]
Potential teratogenic and neurodevelopmental consequences of coffee and caffeine exposure: a review on human and animal data. [1994.11]
Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. [1994.04]
[Pharmacotherapy of headache with special reference to migraine] [1994]
Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials. [1993.08]
Sumatriptan: a new serotonin agonist for the treatment of migraine headache. [1993.02.15]
Sumatriptan in the acute treatment of migraine. [1993.01]
Sumatriptan: a new drug for vascular headache. [1992.11]
Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE. [1992.10]
Severe facial ischaemia caused by ergotism. [1992.05]
Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. [1992.05]
Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. [1991.06.15]
Drug abuse and headache. [1991.05]
[Extremity-threatening ischemia in ergotism. Successful treatment with the intra-arterial administration of nifedipine] [1991.01.25]
Analgesic-induced chronic headache: long-term results of withdrawal therapy. [1989.01]
Acute migraine therapy: recent evidence from randomized comparative trials. [2008.06]
The impact of migraine: a case study. [2007.08]
Prescribing for migraine with the focus on selective 5HT1-receptor agonists: a pharmacy database analysis. [2010.05]
[Observation on therapeutic effect of migraine treated with medicated threads
moxibustion of Zhuang nationality]. [Article in Chinese] [2012]
|